These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22208971)
1. Breast conservation therapy: the influence of molecular subtype and margins. Demirci S; Broadwater G; Marks LB; Clough R; Prosnitz LR Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):814-20. PubMed ID: 22208971 [TBL] [Abstract][Full Text] [Related]
2. Negative margin status improves local control in conservatively managed breast cancer patients. Obedian E; Haffty BG Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736 [TBL] [Abstract][Full Text] [Related]
3. Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer. Vargo JA; Beriwal S; Ahrendt GM; Soran A; Johnson RR; McGuire K; Bhargava R Oncology; 2011; 80(5-6):341-9. PubMed ID: 21791944 [TBL] [Abstract][Full Text] [Related]
4. Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer. Li J; Liu X; Tong Z Jpn J Clin Oncol; 2012 Jun; 42(6):471-6. PubMed ID: 22493058 [TBL] [Abstract][Full Text] [Related]
5. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up. Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U; Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227 [TBL] [Abstract][Full Text] [Related]
6. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561 [TBL] [Abstract][Full Text] [Related]
7. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R Breast J; 2005; 11(4):242-7. PubMed ID: 15982389 [TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes]. Zhang HM; Zhang BN; Xuan LX; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study. Sanpaolo P; Barbieri V; Genovesi D Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576 [TBL] [Abstract][Full Text] [Related]
11. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069 [TBL] [Abstract][Full Text] [Related]
12. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436 [TBL] [Abstract][Full Text] [Related]
13. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262 [TBL] [Abstract][Full Text] [Related]
14. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis? Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
16. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
18. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Wo JY; Taghian AG; Nguyen PL; Raad RA; Sreedhara M; Bellon JR; Wong JS; Gadd MA; Smith BL; Harris JR Int J Radiat Oncol Biol Phys; 2010 May; 77(1):188-96. PubMed ID: 20171798 [TBL] [Abstract][Full Text] [Related]
19. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer? Parker CC; Ampil F; Burton G; Li BD; Chu QD Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045 [TBL] [Abstract][Full Text] [Related]
20. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Parikh RR; Yang Q; Higgins SA; Haffty BG Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):35-42. PubMed ID: 17855007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]